Introduction
============

We sought to study the characteristics and outcomes of ICU patients with carbapenem-resistant (CRKp) and carbapenem-sensitive (CSKp) *K. pneumoniae*infections.

Methods
=======

A retrospective cohort of patients requiring ICU treatment. The study was conducted in an eight-bed ICU between January 2006 and September 2009.

Results
=======

During the study period, 104 patients were diagnosed with *K. pneumoniae*infection. The mean age of patients was 66.3 ± 14.3 years. Fifty-one (49%) were males. The mean APACHE II score was 17.9 ± 6.9. The median duration of hospital stay until the infection was 28 days. Fortyeight patients (46.2%) had bacteremia, 27 (30%) urinary tract infections, 15 (14.4%) pneumonia, seven (6.7%) peritonitis and seven (6.7%) skin and soft tissue infections. Fifty-eight (56.9%) and 39 (39%) patients had previous and concurrent infections, respectively. Seventy-six patients (73.1%) died. The univariate analysis showed that prior hospitalization (*P*= 0.049), dialysis (*P*= 0.034), and history of urologic neoplasia (*P*= 0.041) were associated with the development of carbapenem-resistant infections. No independent risk factors were found in the multivariate analysis. APACHE II score (*P*= 0.003), need for dialysis (*P*= 0.034), shock prior and after the infection (*P*= 0.006 and *P*\< 0.001, respectively), respiratory distress prior and after the infection (*P*= 0.021 and *P*= 0.032, respectively), multiorgan failure prior and after the infection (*P*= 0.02 and *P*= 0.003, respectively), treatment failure (*P*\< 0.001), and acidosis after the development of infection (*P*= 0.003) were associated with death in the univariate analysis. Shock after the infection (*P*= 0.016) and treatment failure (*P*= 0.001) were independent predictors of mortality in the multivariate analysis. No difference in mortality was found between patients with CRKp and CSKp isolates.

Conclusions
===========

Infection due to *K. pneumoniae*in the ICU is associated with high mortality. Infection treatment and hemodynamic support of the patient may be important determinants of the clinical course in critically ill patients with such infections.
